Metabolic effects of phenytoin toxicity. 1986

K J Wagner, and M Zell, and J B Leikin

UI MeSH Term Description Entries
D010672 Phenytoin An anticonvulsant that is used to treat a wide variety of seizures. It is also an anti-arrhythmic and a muscle relaxant. The mechanism of therapeutic action is not clear, although several cellular actions have been described including effects on ion channels, active transport, and general membrane stabilization. The mechanism of its muscle relaxant effect appears to involve a reduction in the sensitivity of muscle spindles to stretch. Phenytoin has been proposed for several other therapeutic uses, but its use has been limited by its many adverse effects and interactions with other drugs. Diphenylhydantoin,Fenitoin,Phenhydan,5,5-Diphenylhydantoin,5,5-diphenylimidazolidine-2,4-dione,Antisacer,Difenin,Dihydan,Dilantin,Epamin,Epanutin,Hydantol,Phenytoin Sodium,Sodium Diphenylhydantoinate,Diphenylhydantoinate, Sodium
D004630 Emergencies Situations or conditions requiring immediate intervention to avoid serious adverse results. Emergency
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

K J Wagner, and M Zell, and J B Leikin
January 1987, Endocrinologie,
K J Wagner, and M Zell, and J B Leikin
April 1979, Annals of internal medicine,
K J Wagner, and M Zell, and J B Leikin
June 2017, JAMA,
K J Wagner, and M Zell, and J B Leikin
November 2022, BMJ case reports,
K J Wagner, and M Zell, and J B Leikin
January 1980, Stroke,
K J Wagner, and M Zell, and J B Leikin
October 2014, The American journal of emergency medicine,
K J Wagner, and M Zell, and J B Leikin
February 1993, Clinical pediatrics,
K J Wagner, and M Zell, and J B Leikin
January 2003, Clinical neuropharmacology,
K J Wagner, and M Zell, and J B Leikin
December 1998, The Annals of pharmacotherapy,
Copied contents to your clipboard!